Mitsugi K - Search Results

1

Efficacy of second-line chemotherapy after treatment with gemcitabine plus nab-paclitaxel or FOLFIRINOX in patients with metastatic pancreatic cancer.

Fukahori M, Okabe Y, Shimokawa M, Otsuka T, Koga F, Ueda Y, Nakazawa J, Komori A, Otsu S, Arima S, Makiyama A, Taguchi H, Honda T, Ushijima T, Miwa K, Shibuki T, Nio K, Ide Y, Ureshino N, Mizuta T, Mitsugi K, Shirakawa T. Fukahori M, et al. Among authors: mitsugi k. Sci Rep. 2023 Nov 8;13(1):19399. doi: 10.1038/s41598-023-46924-0. Sci Rep. 2023. PMID: 37938630 Free PMC article.

2

Simple and efficient chemosensitivity assay for human primary tumor-cells using contact-sensitive microtiter plates.

Mitsugi K, Nakano S, Nakayama M, Ichinose I, Anzai K, Kuroki M, Nakamura M, Nagafuchi S, Niho Y. Mitsugi K, et al. Int J Oncol. 1992 Jul;1(2):141-7. doi: 10.3892/ijo.1.2.141. Int J Oncol. 1992. PMID: 21584523

3

Phase 2 study of modified irinotecan and bolus 5-fluorouracil/l-leucovorin in Japanese metastatic colorectal cancer patients.

Baba E, Fujishima H, Makiyama A, Uchino K, Tanaka R, Esaki T, Kusaba H, Mitsugi K, Nakano S, Akashi K. Baba E, et al. Among authors: mitsugi k. Adv Ther. 2012 Mar;29(3):287-96. doi: 10.1007/s12325-012-0002-3. Epub 2012 Feb 10. Adv Ther. 2012. PMID: 22351434 Clinical Trial.

4

Pemetrexed combined with platinum-based chemotherapy for advanced malignant peritoneal mesothelioma: retrospective analysis of six cases.

Nakano M, Kusaba H, Makiyama A, Ariyama H, Arita S, Oda H, Esaki T, Takayoshi K, Uchino K, Tamura S, Kumagai H, Iwama E, Shirakawa T, Mitsugi K, Takaishi S, Akashi K, Baba E. Nakano M, et al. Among authors: mitsugi k. Anticancer Res. 2014 Jan;34(1):215-20. Anticancer Res. 2014. PMID: 24403465

5

Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan.

Isobe T, Uchino K, Makiyama C, Ariyama H, Arita S, Tamura S, Komoda M, Kusaba H, Shirakawa T, Esaki T, Mitsugi K, Takaishi S, Akashi K, Baba E. Isobe T, et al. Among authors: mitsugi k. Anticancer Res. 2014 Apr;34(4):2035-40. Anticancer Res. 2014. PMID: 24692744

6

Reduced dose of salvage-line regorafenib monotherapy for metastatic colorectal cancer in Japan.

Hirano G, Makiyama A, Makiyama C, Esaki T, Oda H, Uchino K, Komoda M, Tanaka R, Matsushita Y, Mitsugi K, Shibata Y, Kumagai H, Arita S, Ariyama H, Kusaba H, Akashi K, Baba E. Hirano G, et al. Among authors: mitsugi k. Anticancer Res. 2015 Jan;35(1):371-7. Anticancer Res. 2015. PMID: 25550574

7

Amrubicin monotherapy for patients with extrapulmonary neuroendocrine carcinoma after platinum-based chemotherapy.

Nio K, Arita S, Isobe T, Kusaba H, Kohashi K, Kajitani T, Tamura S, Hirano G, Mitsugi K, Makiyama A, Esaki T, Ariyama H, Oda Y, Akashi K, Baba E. Nio K, et al. Among authors: mitsugi k. Cancer Chemother Pharmacol. 2015 Apr;75(4):829-35. doi: 10.1007/s00280-015-2706-y. Epub 2015 Feb 22. Cancer Chemother Pharmacol. 2015. PMID: 25702050

8

Efficacy and safety analysis of chemotherapy for advanced colitis-associated colorectal cancer in Japan.

Nio K, Higashi D, Kumagai H, Arita S, Shirakawa T, Nakashima K, Shibata Y, Esaki M, Manabe T, Nagai S, Ueki T, Nakano M, Ariyama H, Kusaba H, Hirahashi M, Oda Y, Esaki T, Mitsugi K, Futami K, Akashi K, Baba E. Nio K, et al. Among authors: mitsugi k. Anticancer Drugs. 2016 Jun;27(5):457-63. doi: 10.1097/CAD.0000000000000338. Anticancer Drugs. 2016. PMID: 26771865

9

Efficacy and Safety of TAS-102 in Clinical Practice of Salvage Chemotherapy for Metastatic Colorectal Cancer.

Arita S, Shirakawa T, Matsushita Y, Shimokawa HK, Hirano G, Makiyama A, Shibata Y, Tamura S, Esaki T, Mitsugi K, Ariyama H, Kusaba H, Akashi K, Baba E. Arita S, et al. Among authors: mitsugi k. Anticancer Res. 2016 Apr;36(4):1959-66. Anticancer Res. 2016. PMID: 27069187

10

Efficacy and Safety Analysis of Oxaliplatin-based Chemotherapy for Advanced Gastric Cancer.

Inadomi K, Kusaba H, Matsushita Y, Tanaka R, Mitsugi K, Arimizu K, Hirano G, Makiyama A, Ohmura H, Uchino K, Hanamura F, Shibata Y, Kuwayama M, Esaki T, Takayoshi K, Arita S, Ariyama H, Akashi K, Baba E. Inadomi K, et al. Among authors: mitsugi k. Anticancer Res. 2017 May;37(5):2663-2671. doi: 10.21873/anticanres.11614. Anticancer Res. 2017. PMID: 28476842 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page